Skinnate’s objective is to fight certain dermatological diseases through non-invasive nerve simulation devices. The company intends to exploit recent advances and the strong potential of neural simulation for pathologies which have not been explored by theses technologies and which lack therapeutic solutions.Its objectives in the coming years will be to treat dietary disorders and dermatological inflammatory diseases associating state-of-the-art medical device technology with minimally invasive implant surgery.
See website
